ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Braskem removed from B3 indices after extrajudicial restructuring filing

Brazil’s B3 exchange excludes Braskem from all major indices after the petrochemical group filed for a $10.9 billion debt restructuring under extrajudicial recovery. Shares fell 10.7% over two sessions.

PA
Priya Anand · Equities & Earnings Desk · 29 Aug 2026 · 15:51 · 1 min read
Share
Braskem removed from B3 indices after extrajudicial restructuring filing

Brazil’s B3 exchange removed Braskem from all its major stock indices at the close of trading on August 25, 2026, following the company’s filing for an extrajudicial recovery process to restructure approximately $10.9 billion in unsecured debt.

The exclusion affects indices including the Ibovespa, IBrX, IBrX-50, Small Caps, IGCX, IGCT, IMAT, INDX, ISEE, and Itag Along. Braskem’s weight in these portfolios will be redistributed proportionally among remaining constituents, triggering mandatory rebalancing for passive funds tied to the affected indices.

Braskem’s shares declined 6.71% on August 24 to R$4.73, and fell another 4.02% on August 25 to R$4.54, bringing the two-day drop to 10.7%. The company’s largest shareholders—Shine I, an IG4 fund holding 50.11% of voting capital, and Petrobras with 47.03%—retain their stakes.

The restructuring plan, disclosed via a fato relevante, targets only financial obligations and excludes supplier, client, and other stakeholder commitments, which Braskem stated are being met normally. Creditors representing 39.6% of the affected debt have initially supported the proposal, with a 90-day window to finalize agreements, extending into mid-November.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT